Aug 18, 2020  Düsseldorf / Germany

New research collaboration between 3Helix Inc., USA, and Phenion

Cooperation in the field of collagen research

We are happy to announce a research collaboration with 3Helix Inc. (USA), the developer of the Collagen Hybridizing Peptide (CHP) technology which targets damaged or denatured collagen in biological samples with high specificity. This interesting collaboration is investigating skin damage using our Phenion® Full-Thickness Skin Models and 3Helix’s CHPs. By joining forces, we are looking forward to developing an innovative skin testing kit that can provide a standardized way to evaluate skin damage in vitro.


Phenion FT Skin Model stained with H&E (left side) and the R-CHP reagent (after heating). The red staining visualizes the newly synthesized collagen in the dermal compartment of the skin model.